{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:14:12Z","timestamp":1793049252129,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T00:00:00Z","timestamp":1294185600000},"content-version":"vor","delay-in-days":369,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1590\/s1807-59322010001100024","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T18:58:46Z","timestamp":1298573926000},"page":"1197-1205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Glucocorticoid-induced osteoporosis in rheumatic diseases"],"prefix":"10.1016","volume":"65","author":[{"given":"Rosa Maria Rodrigues","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joz\u00e9lio Freire","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Canalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1590\/S1807-59322010001100024_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2008.07.010","article-title":"Use of glucocorticoids and risk of infections","volume":"8","author":"Cutolo","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1590\/S1807-59322010001100024_bib2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1590\/S1807-59322010001100024_bib3","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1590\/S1807-59322010001100024_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S8756-3282(01)00422-7","article-title":"Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture","volume":"28","author":"Pereira","year":"2001","journal-title":"Bone"},{"key":"10.1590\/S1807-59322010001100024_bib5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0961203308094995","article-title":"Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids","volume":"18","author":"Yeap","year":"2009","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10067-008-0984-z","article-title":"Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus","volume":"28","author":"Mendoza-Pinto","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/0961203308094280","article-title":"Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus","volume":"17","author":"Mok","year":"2008","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/kem105","article-title":"Prevalence and risk factors of osteoporosis in female SLE patients-extended report","volume":"46","author":"Almehed","year":"2007","journal-title":"Rheumatology Oxford"},{"key":"10.1590\/S1807-59322010001100024_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10067-006-0258-6","article-title":"Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus","volume":"26","author":"Chong","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kei079","article-title":"Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids","volume":"45","author":"Lee","year":"2006","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1590\/S1807-59322010001100024_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1191\/0961203305lu2154oa","article-title":"High prevalence of vertebral deformity in premenopausal systemic l\u00fapus erythematosus patients","volume":"14","author":"Borba","year":"2005","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib12","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/art.21110","article-title":"Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus","volume":"52","author":"Bultink","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/ard.2003.018127","article-title":"Prevalence and predictors of fragility fractures in systemic lupus erythematosus","volume":"64","author":"Yee","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1191\/0961203303lu1036oa","article-title":"Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density","volume":"13","author":"Pineau","year":"2004","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib15","first-page":"2365","article-title":"Bone mineral density in premenopausal women with systemic lupus erythematosus","volume":"30","author":"Uaratanawong","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10067-003-0743-0","article-title":"Bone mineral density changes in women with systemic lupus erythematosus","volume":"22","author":"Boyanov","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10067-002-8272-9","article-title":"Bone mineral density in women with systemic lupus erythematosus","volume":"21","author":"Bhattoa","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/096120330101001108","article-title":"Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage","volume":"10","author":"Becker","year":"2001","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-001-0149-8","article-title":"Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus","volume":"21","author":"Bhattoa","year":"2001","journal-title":"Rheumatol Int"},{"key":"10.1590\/S1807-59322010001100024_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.59.2.110","article-title":"Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls","volume":"59","author":"Gilboe","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib21","first-page":"1922","article-title":"Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids","volume":"24","author":"Kipen","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/03009740801998747","article-title":"Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis","volume":"37","author":"Book","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/s10165-008-0032-5","article-title":"Characteristics of fracture and related factors in patients with rheumatoid arthritis","volume":"18","author":"Nampei","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib24","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jbspin.2007.01.021","article-title":"Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up","volume":"74","author":"H\u00e4m\u00e4l\u00e4inen","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1590\/S1807-59322010001100024_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2007.073817","article-title":"Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis","volume":"67","author":"G\u00fcler-Y\u00fcksel","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1590\/S0104-42302007000200018","article-title":"Evaluation of body composition and bone mineral density in women with rheumatoid arthritis","volume":"53","author":"Silva","year":"2007","journal-title":"Rev Assoc Med Bras"},{"key":"10.1590\/S1807-59322010001100024_bib27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-004-0989-1","article-title":"Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids","volume":"24","author":"Habib","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib28","first-page":"1020","article-title":"Rheumatoid arthritis: evidence for bone loss in premenopausal women","volume":"32","author":"Tourinho","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib29","first-page":"155","article-title":"Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?","volume":"21","author":"van Everdingen","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/40.12.1375","article-title":"Osteoporosis Working Group, Dutch Society for Rheumaology. Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis","volume":"40","author":"de Nijs","year":"2001","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1590\/S1807-59322010001100024_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/1529-0131(200106)44:6<1254::AID-ART216>3.0.CO;2-G","article-title":"Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease","volume":"44","author":"Kroot","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.59.2.110","article-title":"Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls","volume":"59","author":"Gilboe","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib33","first-page":"451","article-title":"Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy","volume":"64","author":"Cortet","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1590\/S1807-59322010001100024_bib34","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/art.1780361105","article-title":"The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women","volume":"36","author":"Hall","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.48.7.535","article-title":"Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study","volume":"48","author":"Sambrook","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib36","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/ard.45.11.950","article-title":"Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids","volume":"45","author":"Sambrook","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780280403","article-title":"The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state","volume":"28","author":"Als","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib38","first-page":"831","article-title":"Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis","volume":"34","author":"Valta","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00296-002-0265-0","article-title":"Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis","volume":"23","author":"Celiker","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1590\/S1807-59322010001100024_bib40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF01451301","article-title":"Bone mineral density in children with juvenile chronic arthritis","volume":"17","author":"Cetin","year":"1998","journal-title":"Clin Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib41","first-page":"495","article-title":"Evaluation by dual X-ray absorptiometry (DXA) of bone mineral density in children with juvenile chronic arthritis","volume":"16","author":"Pereira","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02555248","article-title":"Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy","volume":"41","author":"Varonos","year":"1987","journal-title":"Calcif Tissue Int"},{"key":"10.1590\/S1807-59322010001100024_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/03009740701687226","article-title":"Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use","volume":"37","author":"Santiago","year":"2008","journal-title":"Scand J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1590\/S0100-879X2005000200020","article-title":"Bone mineral density of Brazilian girls with juvenile dermatomyositis","volume":"38","author":"Castro","year":"2005","journal-title":"Braz J Med Biol Res"},{"key":"10.1590\/S1807-59322010001100024_bib45","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.11211","article-title":"Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry","volume":"48","author":"Stewart","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib46","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0961203308089446","article-title":"The influence of lean mass in trabecular and cortical bone in juvenile onset systemic lupus erythematosus","volume":"17","author":"Regio","year":"2008","journal-title":"Lupus"},{"key":"10.1590\/S1807-59322010001100024_bib47","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/art.21115","article-title":"Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus","volume":"52","author":"Lilleby","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s002960050056","article-title":"Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density","volume":"18","author":"Trapani","year":"1998","journal-title":"Rheumatol Int"},{"key":"10.1590\/S1807-59322010001100024_bib49","first-page":"427","article-title":"Bone mineral density in children wth systemic lupus erythematosus and juvenile rheumatoid arthritis","volume":"27","author":"Kashef","year":"2007","journal-title":"Ann Saudi Med"},{"key":"10.1590\/S1807-59322010001100024_bib50","first-page":"729","article-title":"Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise","volume":"32","author":"Alsufyani","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib51","series-title":"Technical Report Series, No. 843","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis","year":"1994"},{"key":"10.1590\/S1807-59322010001100024_bib53","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1359\/jbmr.090319","article-title":"Repeat Low-Trauma Fractures Occur Frequently Among Men and Women who have Osteopenic Bone Mineral Density","volume":"24","author":"Langsetmo","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1590\/S1807-59322010001100024_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/JCD:7:1:51","article-title":"Standards and guidelines for performing central dual-energy X-ray absorptiometry in premenopausal women, men, and children","author":"Khan","year":"2004","journal-title":"J Clin Densitom"},{"key":"10.1590\/S1807-59322010001100024_bib55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/03009740600704296","article-title":"Systemic sclerosis and bone loss: the role of the disease and body composition","volume":"35","author":"Souza","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib56","first-page":"313","article-title":"Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis","volume":"22","author":"Frediani","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib57","first-page":"1073","article-title":"Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions","volume":"35","author":"Yuen","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib58","first-page":"180","article-title":"Prognostic factors of low bone mineral density in systemic sclerosis","volume":"23","author":"Sampaio-Barros","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02529727","article-title":"A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica","volume":"58","author":"Healey","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1590\/S1807-59322010001100024_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2796.1990.tb00177.x","article-title":"Osteoporosis after long-term corticosteroid treatment of giant cell arteritis","volume":"227","author":"Andersson","year":"1990","journal-title":"J Intern Med"},{"key":"10.1590\/S1807-59322010001100024_bib61","first-page":"213","article-title":"Polymyalgia rheumatica and giant cell arteritis; diagnosis and side effects of low-dose long-term glucocorticoid therapy","volume":"51","author":"Hatz","year":"1992","journal-title":"Z Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/rheumatology\/37.3.292","article-title":"The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica","volume":"37","author":"Pearce","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib63","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update","volume":"44","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib64","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1001\/archinte.163.21.2619","article-title":"Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs","volume":"163","author":"Adler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1590\/S1807-59322010001100024_bib65","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard.2003.008060","article-title":"Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology","volume":"63","author":"Geusens","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1590\/S1807-59322010001100024_bib66","series-title":"Glucocorticoid-induced Osteoporosis: guidelines for prevention and treatment","author":"National Osteoporosis Society & Royal College of Physicians guidelines working group for Bone and Tooth Society","year":"2002"},{"key":"10.1590\/S1807-59322010001100024_bib67","first-page":"1651","article-title":"Trends in prevention of glucocorticoid-induced osteoporosis","volume":"33","author":"Saag","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1590\/S1807-59322010001100024_bib68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/art.22462","article-title":"Barriers in the management of glucocorticoid-induced osteoporosis","volume":"57","author":"Guzman-Clark","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1590\/S1807-59322010001100024_bib69","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4065\/80.2.194","article-title":"Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions","volume":"80","author":"Solomon","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1590\/S1807-59322010001100024_bib70","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MED.0b013e3282f15407","article-title":"Glucocorticoid-induced osteoporosis","volume":"14","author":"Berris","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1590\/S1807-59322010001100024_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jsbmb.2005.06.020","article-title":"The vitamin D requirement in health and disease","volume":"97","author":"Heaney","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1590\/S1807-59322010001100024_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1590\/S1807-59322010001100024_bib73","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1590\/S1807-59322010001100024_bib74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1568-9972(03)00056-9","article-title":"Management of glucocorticoid induced osteoporosis in premenopausal women with autoimmune disease","volume":"2","author":"Franchimont","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1590\/S1807-59322010001100024_bib75","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S1701-2163(16)34026-9","article-title":"Does treatment with bisphosphonates endanger the human pregnancy?","volume":"30","author":"Djokanovic","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1590\/S1807-59322010001100024_bib76","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bone.2008.11.001","article-title":"Pregnancy outcome following in utero exposure to bisphosphonates","volume":"44","author":"Levy","year":"2009","journal-title":"Bone"},{"key":"10.1590\/S1807-59322010001100024_bib77","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1590\/S1807-59322010001100024_bib78","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222029088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222029088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.scielo.br\/pdf\/clin\/v65n11\/24.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:16:33Z","timestamp":1761722193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222029088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":77,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1807593222029088"],"URL":"https:\/\/doi.org\/10.1590\/s1807-59322010001100024","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid-induced osteoporosis in rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1590\/S1807-59322010001100024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}